← Open Payments lookup

FERNANDO TAVERAS: Open Payments

NPI 1194769067 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,880 in 191 payments from 15 companies in 2025. Trend: 2023 $2,509 · 2024 $2,694 · 2025 $4,880

Food & beverage: $4,786Education: $94
CompanyPaymentsAmount
Alkermes, Inc.39$1,068
Axsome Therapeutics, Inc.23$591
ABBVIE INC.23$575
E.R. Squibb & Sons, L.L.C.16$495
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$411
Otsuka America Pharmaceutical, Inc.21$395
Vanda Pharmaceuticals Inc.11$341
Teva Pharmaceuticals USA, Inc.13$297
Neurocrine BioSciences, Inc.13$268
Lundbeck LLC13$204

Products named: Auvelity, VIVITROL, VRAYLAR, COBENFY, REXULTI, CAPLYTA, ARISTADA, INGREZZA.

Industry payments across NY — which companies pay providers there.